Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The market cap of AXIM is $23.9 million according to IBKR. If DED tests become popular and the ImmunoPass were to become approved, what metrics would investors use to put a valuation on AXIM?
Thanks
The $10 cost of the test kit to doctors and the $17 reimbursement from insurance, does that refer to one test or the four tests all together(two tests and two eyes)?
This is maybe a potential 10-20 million tests per year. That would be up to $200 million in revenue if that happened.
I think when I say test I am referring to a group of four tests.
Is this near future high percentage chance of revenues for DED being priced into the current AXIM stock price of 17 cents at this time?
And ImmunoPass should still be deemed to have a significant chance at approval somewhere in the world I think.
Thanks
Is the 12 million shares sold today due to the company engaging in dilution to raise funds? Or is it flippers ensuring that they realize their 20% gain before it all evaporates away?
What is the potential market size for our dry eye disease tests? Is it for the ophthalmology and optometry professionals to use or for the general population to use at home? My understanding is that DED is related to inflammation. What marker of inflammation are we measuring? Thanks
If you look at a three year chart there are many spikes upwards in price. Triples and home runs happen two or three times per year in the history.
The key thing is that it is a spike. That means that the sell action need to be a fast decision. If you snooze you lose. This is demonstrated over and over again.
Is this company mostly about ibogaine which is a chemical in certain species of mushrooms?
Corticotropin is not the catalyst everybody thought that it could be it seems.
I thought it was an interesting observational speculation that included a humorous component.
What is the price for a bottle of Hip Water?
If we get a 200 to 1 reverse split, then it is after that occurrence and the subsequent sell off and stock sales that a retail investor might be able to buy this.
Where does the manufacture and packaging of VitaStem occur? Is the ViaDerma Distribution Company working hard for us?
This is my only green stock today. Up 5%. Is anyone here concerned that this could be a share selling scheme that is using Kathy Ireland to sell shares along with the medical devices?
There are 650 million shares outstanding. The authorized shares are 3 billion. The company may be planning to sell many shares into the near future. Is this a major concern?
Has Jimmy already made all the money he would need to comfortably retire?
The sale of shares creates a value that ends up in Jimmy’s pocket. The share holders acquire the distinction of becoming bag holders.
Over on another stock board they are saying that 3 billion shares of CATV are being held short. Is this true?
I remember IG saying that being short a stinker pinkie is too dangerous to do in practice.
Did they borrow the 3 billion shares to short or are they doing a naked short? Is this naked short legal and proper?
On IBKR the margin required to go short CATV is enormous.
It has been said that Empowered is producing our ImmunoPass test kits already to build up inventory before an EUA gets issued. Is there an expiration date on the test kits?
What is approximate cost of manufacture per lateral flow test?
There might be a sizable inventory at this time ready for use.
In the field of wearable medical sensors there probably are several other well funded competitors in direct competition with WHSI.
Can somebody explain why it is that WHSI is special, will explode upwards and can compete successfully? Thanks
No trades today as of yet. I wonder whether Canadians could buy if they wanted to.
Up 19,000% today
I thought that 0.0001 was the bottom. Now quoting a price of 0.000001 down 97% from yesterday’s price of 0.0001.
If Vyleesi could be a patch it would be a big seller.
The upside potential has been discussed. What is the downside risk here? Thanks
Is today the last day of tax loss selling? Does it take 3 days for the trade to settle?
Thank you MallenNV. I really appreciate your detailed informative post. I have never seen this content elucidated before. When you went short at 18 cents how much margin did you put up to go short? Covering an 18 cent short at 0.005 is an amazing profit with no risk the way you describe it.
You seem to be asserting that the CEO Jimmy Chan was also short SGMD stock and profiting massively by the plummeting down of the stock price. Is this legal for a CEO to short his own company? Isn’t the fiduciary responsibility of a CEO to put his or her efforts into promoting the interests of the company’s shareholders?
I will read your post several times over until I fully understand what you have explained to me that I was not aware to be happening.
Thanks again and Happy New Year.
Initial margin to short SGMD at Interactive Brokers is 250000%. Shorting ultra micro caps has been said to be so risky that nobody really shorts these stocks. That is what they say.
In reality perhaps they really do short them. They do not do it correctly by first borrowing the shares. Instead they naked short illegally and the SEC does not enforce the rules. Is this any less risky?
Each stinky pinky has its detractors. I could never figure out why they are there. What. Is in it for them? They say they are doing altruistic service for naive new investors. Are people really so altruistic?
Is Jimmy Chan on the SEC or the DOJ radar as a possible scammer to be investigated?
What could it be that would cause Schwab to change their mind? Who makes these decisions?
Remi our CEO has bought new land with two buildings on it to expand operations in Austin, TX. He seems very confident in the interview about the prospects of success. The open label study which is being harshly criticized for lax controls was just to get a glimpse ahead of time of efficacy.
He acknowledges that it is the double bind placebo controlled phase 3 studies that will determine whether we are successful or another case after a very long list of Alzheimer’s investigational drug clinical failures that have occurred over the past 30 years.
He also said that if he were CEO of Biogen that he would have had the humanitarian conscience and the responsibility to society to never have filed for approval of a drug that does not work and causes brain inflammation.
This stock was $10 in May 2021. It was nonstop severely terrible stock performance since then. Down 85% in 6 months.
Whatever happened to NSI-189 which grew neurons in the hippocampus?
I saw him post about a month ago here that he was still long CATV. Perhaps until the CE gets lifted there is nothing really much that is relevant to say. A smart person might just conserve their energy by avoiding the inevitable FUD and malaise that is to be expected in our unfortunate current situation and our miserable stock price.
The previous large upswing for VDRM was $0.0015 to $0.076. If a similar new upswing should be auspicious enough to occur it would be from 1 cent where we are now to around 42 cents. Last year the run up was from Jan to March. Many micro caps all went up at the same time.
Wallet Investor which is AI based has VDRM above $2.00 in June 2022. Holding for $2.00 in my view however might not be a wise exit plan. Actually a smart person would likely sell following any and each parabolic upward move. They would know from experience that they can almost always buy back in at a lower price and then have a larger share count going forward plus bag for themselves some cash as profit as well.
I know that Wallet Investor does not have any credibility. It is fun though just to throw that $2.00 number out there into the environment as a possible prediction that a programmed computer could make.
The stainless formula for tetracycline, VitaStem, may have been important for the hospital contract.
The new VitaStem might have a greater usage in the adolescent acne market. I think that there could be a sizable topical acne market. Dermatologists and Family Practice MDs should be informed about our product. A topical would cause less complications or side effects than a systemic drug.
There is also the analgesic spray and the other antibiotic I think that is bacitracin gel. Dr. Otiko has mentioned PME, CBD, ED, and maybe other applications for the transdermal technology.
WC Wainwright raised the PT from $2 to $5. Is there something new that they found out about? Is there new clinical dry eye treatment data? Is Vyleesi exceeding expectations? Is it the Ulcerative Colitis drug? Is it a recent presentation regarding treatment for diabetic retinopathy presented to retinal specialists?
120,000 million shares traded today. Analyst recommendations usually do not have as large an impact as this one did.
What is an “Exempt Offering of Securities”. Exempt from what exactly?
Would a reverse split and then a discounted stock offering be in the near future for NVIV. Would that harm the interests of our senior management officers? I think they must accept only cash compensation.
500,000,000 outstanding shares at 0.0001 equals $50,000 to own all the shares. Who has the rights to the patent at this time? Is it the judge in Israel that has the authority to simply sell the patent to pay higher priority OWCP creditors?
What is the IP really worth?
Market Cap of CATV is currently $7.4M.
0.0001 today
Toe Nail Fungus treatments need to penetrate the nail and surrounding skin to cure this common condition. I wonder whether Dr. Otiko has looked at this application for the VDRM technology.
Then there was ED, CBD, Pain, Premature Ejaculation, and other potential applications in addition to the antibiotic uses.
Up 28%. Volume so far today is 5.8 million shares. Daily average is 3.6 million.